Clinical Trial Update: Trial of First-line L-glutamine With Gemcitabine and Nab-paclitaxel in Advanced Pancreatic Cancer [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating first-line L-glutamine in combination with gemcitabine and nab-paclitaxel for advanced pancreatic cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Ductal Adenocarcinoma

Drugs mentioned

• Gemcitabine (Gemzar) (gemcitabine)
• L-GLUTAMINE (L-Glutamine)
• Nab-paclitaxel (Abraxane) (nab-paclitaxel)

Snippet

Sponsor: Jun Gong, MD | Conditions: Advanced Pancreatic Adenocarcinoma, Pancreatic Cancer | Phase 1 | Status: COMPLETED